INMB — INmune Bio Inc.

INMBINmune Bio Inc.

NAS · US · Healthcare · Biotechnology · inmunebio.com

1.395USD-1.06%Mkt Cap: 36.98M USDP/E: —Last update: 2026-06-01

INmune Bio Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States. It intends to develop and commercialize product cand…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap36.98M USD

Enterprise Value17.64M USD

Revenue (TTM)0 USD

Gross Profit0 USD

Net Income (TTM)-45.93M USD

Revenue/Share0.0000 USD

Last Price1.395 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees21

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-2.69

PEG—

EV/EBITDA—

EV/Revenue—

P/SInfinity

P/B1.91

EPS (TTM)-1.63

EPS (Forward)-0.53

52W Range

1.0903% of range11.64

52W High11.64 USD

52W Low1.090 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin-91866.00%

ROE-195.26%

ROA-141.98%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-22.58M USD

CapEx (TTM)1.04M USD

FCF Margin—

FCF Yield-30.41%

Net Debt-19.85M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.04

Current Ratio4.24

Quick Ratio4.11

Book Value/Sh0.7380 USD

Cash/Share0.8030 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.3 (Strong Buy)

Target (Mean)7.000 USD

Target Range4.000 USD – 9.000 USD

# Analysts4

Ownership

Shares Out.26.59M

Float22.16M

Insiders11.16%

Institutions19.70%

Short Interest

Short Ratio8.3d

Short % Float15.42%

Short % Out.13.70%

Shares Short3.64M

Short (prev mo.)3.37M

Technical

SMA 501.353 (+3.1%)

SMA 2001.652 (-15.6%)

Beta1.05

S&P 52W Chg27.94%

Avg Vol (30d)380.69K

Avg Vol (10d)716.55K

Technical Indicators

RSI (14)48.9

MACD0.0075

MACD Signal0.0216

MACD Hist.-0.0141

BB Upper1.608 USD

BB Middle1.458 USD

BB Lower1.309 USD

BB Width20.45%

ATR (14)0.0957 USD

Vol Ratio (20d)0.56x